January 11, 2018
Year 2020 has been set as the delivery date for 500,000 whole exome sequences from the UK Biobank cohorts. A consortium of six drug companies will […]
January 10, 2018
– Inked new collaboration and commercialization deals with MGI to leverage Curetis´ sample preparation technology – Enabling short-term commercialization of NGS-based molecular microbiology Amsterdam, the Netherlands, […]
January 8, 2018
Originally published January 7, 2018 at 5:43 pm Dr. Robert Day, former director of the Fred Hutchinson Cancer Center who brought the campus to South Lake […]
January 8, 2018
– Review of the Unyvero System and Lower Respiratory Tract (LRT) Cartridge is nearing completion – U.S. commercial team and operational infrastructure in place Amsterdam, the […]
December 20, 2017
Dec 19, 2017 NEW YORK (GenomeWeb) – Epigenomics announced today that it has received CE-IVD marking for its blood-based lung cancer test Epi proLung. Epi proLung […]
November 30, 2017
Key Tips for Diagnostics in 2018 and Beyond: Development Success in the Evolving US and EU Landscape
TORONTO, ON–(Marketwired – November 29, 2017) – In an upcoming webinar hosted by Xtalks on Thursday, December 14, 2017, leading diagnostics specialty CRO Health Decisions will introduce […]
November 27, 2017
21. NOVEMBER 2017. Berlin (Germany) and Germantown, MD (U.S.A.), November 21, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) announced the Centers of Medicare […]
November 16, 2017
Curetis Publishes Business and Financial Update for the First Nine Months of 2017 – Preparing for expected U.S. FDA clearance decision on Unyvero System and Unyvero […]
October 23, 2017
Curetis initiates U.S. FDA Study for Unyvero Invasive Joint Infections Cartridge – Initial patient samples collected for second U.S. Unyvero Product Study – Prospective clinical trial expected to […]
